AAAAAA
Results: 1-25/38
Authors:
Maijgren-Steffensson, C
Sonnerborg, A
Vahlne, A
Britton, S
Larsson, S
Ahrlund-Richter, L
Citation: C. Maijgren-steffensson et al., Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1, MOL THER, 3(4), 2001, pp. 531-535
Authors:
Vandamme, AM
Houyez, F
Banhegyi, D
Clotet, B
De Schrijver, G
De Smet, KAL
Hall, WW
Harrigan, R
Hellmann, N
Hertogs, K
Holtzer, C
Larder, B
Pillay, D
Race, E
Schmit, JC
Schuurman, R
Shulse, E
Sonnerborg, A
Miller, V
Citation: Am. Vandamme et al., Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up, ANTIVIR TH, 6(1), 2001, pp. 21-39
Authors:
Never, L
Ehrnst, A
Belfrage, E
Blomberg, J
Christensson, B
Forsgren, M
Lidin-Janson, G
Lindgren, S
Ljung, R
Sonnerborg, A
Bohlin, AB
Citation: L. Never et al., Broad spectrum of time of detection, primary symptoms and disease progression in infants with HIV-1 infection, EUR J CL M, 20(3), 2001, pp. 159-166
Authors:
Karlsson, AC
Birk, M
Lindback, S
Gaines, H
Mittler, JE
Sonnerborg, A
Citation: Ac. Karlsson et al., Initiation of therapy during primary HIV type 1 infection results in a continuous decay of proviral DNA and a highly restricted viral evolution, AIDS RES H, 17(5), 2001, pp. 409-416
Authors:
Visco-Comandini, U
Aleman, S
Yun, Z
Sonnerborg, A
Citation: U. Visco-comandini et al., Human immunodeficiency virus type 1 variability and long-term non-progression, J BIOL REG, 15(3), 2001, pp. 299-303
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
Birk, M
Svedhem, V
Sonnerborg, A
Citation: M. Birk et al., Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy, AIDS, 15(11), 2001, pp. 1359-1368
Authors:
Rastad, AA
Andersson, J
Beermann, B
Bohlin, AB
Brandt, C
Eriksson, M
Ewald, U
Gothberg, S
Lind, A
Lindroth, M
Ljungman, P
Naver, L
Norrby, SR
Pauksen, K
Ransjo, U
Rebbel, H
Ostlund, MR
Sigurs, N
Stahle, L
Sawe, J
Sonnerborg, A
Uhnoo, I
Stopner, BA
Citation: Aa. Rastad et al., Management of infections caused by respiratory syncytial virus, SC J IN DIS, 33(5), 2001, pp. 323-328
Authors:
Karlsson, AC
Lindkvist, A
Lindback, S
Gaines, H
Sonnerborg, A
Citation: Ac. Karlsson et al., Recent origin of human immunodeficiency virus type 1 variants in resting CD4(+) T lymphocytes in untreated and suboptimally treated subjects, J INFEC DIS, 184(11), 2001, pp. 1392-1401
Authors:
Lore, K
Spetz, AL
Fehniger, TE
Sonnerborg, A
Landay, AL
Andersson, J
Citation: K. Lore et al., Quantitative single cell methods that identify cytokine and chemokine expression in dendritic cells, J IMMUNOL M, 249(1-2), 2001, pp. 207-222
Authors:
Goh, LE
McDade, H
Kinloch, S
Perrin, L
Cooper, D
Phillips, A
Hoen, B
Autran, B
Sonnerborg, A
Tsoukas, C
Citation: Le. Goh et al., The Quest Trial, a paradigm of HIV collaborative research, NAT MED, 6(11), 2000, pp. 1194-1194
Authors:
Iroegbu, J
Birk, M
Lazdina, U
Sonnerborg, A
Sallberg, M
Citation: J. Iroegbu et al., Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies, CL DIAG LAB, 7(3), 2000, pp. 377-383
Authors:
De Milito, A
Hejdeman, B
Albert, J
Aleman, S
Sonnerborg, A
Zazzi, M
Chiodi, F
Citation: A. De Milito et al., High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy, AIDS RES H, 16(14), 2000, pp. 1379-1384
Authors:
Lindback, S
Karlsson, AC
Mittler, J
Blaxhult, A
Carlsson, M
Briheim, G
Sonnerborg, A
Gaines, H
Citation: S. Lindback et al., Viral dynamics in primary HIV-1 infection, AIDS, 14(15), 2000, pp. 2283-2291
Authors:
Lindback, S
Thorstensson, R
Karlsson, AC
von Sydow, M
Flamholc, L
Blaxhult, A
Sonnerborg, A
Biberfeld, G
Gaines, H
Citation: S. Lindback et al., Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure, AIDS, 14(15), 2000, pp. 2333-2339
Authors:
Svensson, JO
Sonnerborg, A
Stahle, L
Citation: Jo. Svensson et al., Rapid and simple determination of indinavir in serum, urine, and cerebrospinal fluid using high-performance liquid chromatography, THER DRUG M, 22(5), 2000, pp. 626-629
Authors:
Gyllensten, K
Sonnerborg, A
Stahle, L
Citation: K. Gyllensten et al., Switching antiretroviral therapy from an enzyme-inducing drug, THER DRUG M, 22(5), 2000, pp. 637-638
Authors:
Wejstal, R
Fischler, B
Glaumann, H
Norkrans, G
Reichard, O
Sonnerborg, A
Uhnoo, I
Weiland, O
Citation: R. Wejstal et al., Chronic hepatitis C - Swedish experts' meeting recommends combination treatment, SC J IN DIS, 32(5), 2000, pp. 465-470
Authors:
Aleman, S
Pehrson, P
Sonnerborg, A
Citation: S. Aleman et al., Kinetics of beta-chemokine levels during anti-HIV therapy, ANTIVIR TH, 4(2), 1999, pp. 109-115
Authors:
Sagoe, KWC
Britton, S
Mingle, JAA
Affram, K
Djokoto, A
Sonnerborg, A
Citation: Kwc. Sagoe et al., Similar HIV-1 subtype A V3 loop sequences are found in dual HIV-1/HIV-2 and HIV-1-only seropositives in Ghana, AIDS RES H, 15(8), 1999, pp. 775-779
Authors:
Visco-Comandini, U
Yun, ZB
Vahlne, A
Sonnerborg, A
Citation: U. Visco-comandini et al., No association of HIV type 1 long terminal repeat sequence pattern with long-term nonprogression and in vivo viral replication levels in European subjects, AIDS RES H, 15(7), 1999, pp. 609-617
Authors:
Bjorndal, A
Sonnerborg, A
Tscherning, C
Albert, J
Fenyo, EM
Citation: A. Bjorndal et al., Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients, AIDS RES H, 15(7), 1999, pp. 647-653
Authors:
Naghavi, MH
Salminen, MO
Sonnerborg, A
Vahlne, A
Citation: Mh. Naghavi et al., DNA sequence of the long terminal repeat of human immunodeficiency virus type I subtype A through G, AIDS RES H, 15(5), 1999, pp. 485-488
Authors:
Aleman, S
Visco-Comandini, U
Lore, K
Sonnerborg, A
Citation: S. Aleman et al., Long-term effects of antiretroviral combination therapy on HIV type 1 DNA levels, AIDS RES H, 15(14), 1999, pp. 1249-1254
Authors:
Naghavi, MH
Schwartz, S
Sonnerborg, A
Vahlne, A
Citation: Mh. Naghavi et al., Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1, AIDS RES H, 15(14), 1999, pp. 1293-1303